EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Folate transfer in placental choriocarcinoma cells treated with valproic acid: Insights gained through comparisons with the amide derivative sec ‐butylpropylacetamide and its individual stereoisomers

Natalia Erenburg iD, Roa'a Hamed iD, Alina Nemirovski iD, Meir Bialer iD, Sara Eyal iD

Epilepsia · 2025

DOI: 10.1111/epi.18470 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Epilepsia, 2025. Verfasst von Natalia Erenburg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Valproic Acid, Folic Acid, Placenta, Anticonvulsants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We have previously shown that valproic acid (VPA) alters the expression of placental carriers of essential nutrients, including folates. Here, we exposed a placental cell line to VPA, its central nervous system‐active amide derivative sec ‐butylpropylacetamide (SPD), and its individual stereoisomers to address the question of whether folate carrier expression can predict the teratogenicity of VPA‐related compounds. We additionally conducted a pilot analysis of folate transfer across placental cell monolayers to estimate the translation of altered carrier expression to carrier activity.

Methods

BeWo cells were incubated for 2 or 5 days with racemic SPD, its stereoisomers (2S,3S)‐SPD, (2R,3S)‐SPD, and (2R,3R)‐SPD (previously found to be teratogenic at high doses in mice; .5 or 1 mmol·L −1 ), VPA (1 mmol·L −1 = 144 mg/L), or their vehicle. Expression of FOLR1 (folate receptor alpha), SLC19A1 (reduced folate carrier), and ABCG2 (breast cancer resistance protein) was measured by real‐time polymerase chain reaction. Folate transfer across monolayers of BeWo b30 cells exposed to .5 mmol·L −1 (2R,3R)‐SPD or 1 mmol·L −1 VPA was quantified by liquid chromatography–mass spectrometry analysis.

Results

At 1 mmol·L −1 , racemic SPD, (2S,3S)‐SPD, and (2R,3S)‐SPD reduced by twofold SLC19A1 expression, similar to VPA ( p < .001). SPD and its enantiomers induced FOLR1 expression by up to twofold ( p < .05) or did not significantly affect it, and racemic SPD increased ABCG2 expression ( p < .01). After 5 days, VPA, but not (2R,3R)‐SPD, enhanced both maternal‐to‐fetal and fetal‐to‐maternal folate transfer ( p < .01), resulting in a 15% increase in net transfer in the fetal direction. Significance Altered expression of the studied carriers could not explain the folate transfer kinetics across placental cell monolayers. Future studies should assess the effects of VPA and other antiseizure medications on transplacental transfer of essential compounds in vivo and the ability to predict it by functional in vitro assays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Valproic AcidFolic AcidPlacentaAnticonvulsantsChoriocarcinomaHumansFemalePregnancyStereoisomerismFolate Receptor 1Cell Line, TumorReduced Folate Carrier ProteinATP Binding Cassette Transporter, Subfamily G, Member 2Biological TransportNeoplasm Proteins

Stichwörter der Autor:innen

BeWo cellsantiseizure medicationsfolate carrierspregnancyteratogenicity

Substanzen

Valproic AcidFolic AcidFolate Receptor 1Reduced Folate Carrier ProteinAnticonvulsantsATP Binding Cassette Transporter, Subfamily G, Member 2FOLR1 protein, humanSLC19A1 protein, humanABCG2 protein, humanNeoplasm Proteins

Autor:innen und Institutionen

  • Institute for Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • David R. Bloom Center for Pharmacy, Hebrew University of Jerusalem, Jerusalem, Israel.

ORCID-Profile: Natalia Erenburg, Roa'a Hamed, Alina Nemirovski, Meir Bialer, Sara Eyal

Förderung

  • Israel Science Foundation

Zitieren

APA

Erenburg, N., Hamed, R., Nemirovski, A., Bialer, M., & Eyal, S. (2025). Folate transfer in placental choriocarcinoma cells treated with valproic acid: Insights gained through comparisons with the amide derivative sec ‐butylpropylacetamide and its individual stereoisomers. Epilepsia. https://doi.org/10.1111/epi.18470

Vancouver

Erenburg N, Hamed R, Nemirovski A, Bialer M, Eyal S. Folate transfer in placental choriocarcinoma cells treated with valproic acid: Insights gained through comparisons with the amide derivative sec ‐butylpropylacetamide and its individual stereoisomers. Epilepsia. 2025. doi:10.1111/epi.18470

BibTeX
@article{Erenburg2025,
  author = {Erenburg, Natalia and Hamed, Roa'a and Nemirovski, Alina and Bialer, Meir and Eyal, Sara},
  title = {Folate transfer in placental choriocarcinoma cells treated with valproic acid: Insights gained through comparisons with the amide derivative sec ‐butylpropylacetamide and its individual stereoisomers},
  journal = {Epilepsia},
  year = {2025},
  doi = {10.1111/epi.18470}
}
Kostenlos starten →